Literature DB >> 15939918

Borderline personality disorder.

Joel Paris1.   

Abstract

Borderline personality disorder is a chronic psychiatric disorder characterized by marked impulsivity, instability of mood and interpersonal relationships, and suicidal behaviour that can complicate medical care. Identifying this diagnosis is important for treatment planning. Although the cause of borderline personality disorder is uncertain, most patients improve with time. There is an evidence base for treatment using both psychotherapy and psychopharmacology. The clinical challenge centres on managing chronic suicidality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15939918      PMCID: PMC558173          DOI: 10.1503/cmaj.045281

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  49 in total

Review 1.  Family studies of borderline personality disorder: a review.

Authors:  Candace N White; John G Gunderson; Mary C Zanarini; James I Hudson
Journal:  Harv Rev Psychiatry       Date:  2003 Jan-Feb       Impact factor: 3.732

2.  Borderline personality disorder criteria associated with prospectively observed suicidal behavior.

Authors:  Shirley Yen; M Tracie Shea; Charles A Sanislow; Carlos M Grilo; Andrew E Skodol; John G Gunderson; Thomas H McGlashan; Mary C Zanarini; Leslie C Morey
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

3.  Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder.

Authors:  Elizabeth B Simpson; Shirley Yen; Ellen Costello; Karen Rosen; Ann Begin; Jacqueline Pistorello; Teri Pearlstein
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

4.  History of multiple suicide attempts as a behavioral marker of severe psychopathology.

Authors:  Evan M Forman; Michele S Berk; Gregg R Henriques; Gregory K Brown; Aaron T Beck
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

5.  A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

Authors:  Mary C Zanarini; Frances R Frankenburg; Elizabeth A Parachini
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

6.  Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.

Authors:  Joel Paris; Hallie Zweig-Frank; N M K Ng Ying Kin; George Schwartz; Howard Steiger; N P V Nair
Journal:  Psychiatry Res       Date:  2004-01-01       Impact factor: 3.222

7.  Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages.

Authors:  Stephen P Hinshaw
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

8.  Olanzapine versus placebo in the treatment of borderline personality disorder.

Authors:  Michael P Bogenschutz; H George Nurnberg
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

9.  Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands.

Authors:  Roel Verheul; Louise M C Van Den Bosch; Maarten W J Koeter; Maria A J De Ridder; Theo Stijnen; Wim Van Den Brink
Journal:  Br J Psychiatry       Date:  2003-02       Impact factor: 9.319

10.  Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial.

Authors:  Martin Bohus; Brigitte Haaf; Timothy Simms; Matthias F Limberger; Christian Schmahl; Christine Unckel; Klaus Lieb; Marsha M Linehan
Journal:  Behav Res Ther       Date:  2004-05
View more
  13 in total

Review 1.  Treatment for comorbid borderline personality disorder and alcohol use disorders: a review of the evidence and future recommendations.

Authors:  Mayumi O Gianoli; J Serrita Jane; Erin O'Brien; Elizabeth Ralevski
Journal:  Exp Clin Psychopharmacol       Date:  2012-06-11       Impact factor: 3.157

2.  Personality traits as prospective predictors of suicide attempts.

Authors:  S Yen; M T Shea; C A Sanislow; A E Skodol; C M Grilo; M O Edelen; R L Stout; L C Morey; M C Zanarini; J C Markowitz; T H McGlashan; M T Daversa; J G Gunderson
Journal:  Acta Psychiatr Scand       Date:  2009-03-03       Impact factor: 6.392

3.  Outcome of crisis intervention for borderline personality disorder and post traumatic stress disorder: a model for modification of the mechanism of disorder in complex post traumatic syndromes.

Authors:  Andreas Laddis
Journal:  Ann Gen Psychiatry       Date:  2010-04-27       Impact factor: 3.455

4.  Types of borderline personality disorder (BPD) in patients admitted for suicide-related behavior.

Authors:  Federico Rebok; Germán L Teti; Adrián P Fantini; Christian Cárdenas-Delgado; Sasha M Rojas; María N C Derito; Federico M Daray
Journal:  Psychiatr Q       Date:  2015-03

5.  Intervention Effect of Repetitive TMS on Behavioral Adjustment After Error Commission in Long-Term Methamphetamine Addicts: Evidence From a Two-Choice Oddball Task.

Authors:  Qiongdan Liang; Jia Lin; Jiemin Yang; Xiang Li; Yijiang Chen; Xianxin Meng; Jiajin Yuan
Journal:  Neurosci Bull       Date:  2018-01-16       Impact factor: 5.203

6.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12

7.  Self and identity in women with symptoms of borderline personality: A qualitative study.

Authors:  Gillian Agnew; Ciarán Shannon; Tina Ryan; Lesley Storey; Catherine McDonnell
Journal:  Int J Qual Stud Health Well-being       Date:  2016-03-23

Review 8.  Patients with Borderline Personality Disorder in Emergency Departments.

Authors:  Untara Shaikh; Iqra Qamar; Farhana Jafry; Mudasar Hassan; Shanila Shagufta; Yassar Islamail Odhejo; Saeed Ahmed
Journal:  Front Psychiatry       Date:  2017-08-04       Impact factor: 4.157

9.  Informed consent for research in Borderline Personality Disorder.

Authors:  Rachel E Dew
Journal:  BMC Med Ethics       Date:  2007-05-10       Impact factor: 2.652

10.  Borderline Personality Disorder Symptoms in College Students: The Complex Interplay between Alexithymia, Emotional Dysregulation and Rumination.

Authors:  Rebecca Meaney; Penelope Hasking; Andrea Reupert
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.